Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Devor

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Science (London, England : 1979)|January 27, 2018
Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsiaSabrina M Scroggins, Donna A Santillan, Jenna M Lund, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2023
Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric riskSerena B Gumusoglu, Michaela D Kiel, Aleigha Gugel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
<i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyKristina W Thiel, Eric J Devor, Virginia L Filiaci, et al.
Genes|October 10, 2020
Detargeting Lentiviral-Mediated CFTR Expression in Airway Basal Cells Using miR-106bSoon H Choi, Rosie E Reeves, Guillermo S Romano Ibarra, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2023
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targetsKristina W Thiel, Andreea M Newtson, Eric J Devor, et al.
Gynecologic Oncology|May 24, 2017
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group studyHenry D Reyes, Jeffrey Miecznikowski, Jesus Gonzalez-Bosquet, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Gynecologic Oncology|February 5, 2021
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology studyKimberly K Leslie, Virginia L Filiaci, Adrianne R Mallen, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 2019
Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated With Human Preeclampsia and Sufficient to Cause Features of the Disorder in MiceKatherine J Perschbacher, Guorui Deng, Jeremy A Sandgren, et al.
Frontiers in Plant Science|March 5, 2016
RNA Interference for Functional Genomics and Improvement of Cotton (Gossypium sp.)Ibrokhim Y Abdurakhmonov, Mirzakamol S Ayubov, Khurshida A Ubaydullaeva, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Science (London, England : 1979)|January 27, 2018
Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsiaSabrina M Scroggins, Donna A Santillan, Jenna M Lund, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2023
Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric riskSerena B Gumusoglu, Michaela D Kiel, Aleigha Gugel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
<i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyKristina W Thiel, Eric J Devor, Virginia L Filiaci, et al.
Genes|October 10, 2020
Detargeting Lentiviral-Mediated CFTR Expression in Airway Basal Cells Using miR-106bSoon H Choi, Rosie E Reeves, Guillermo S Romano Ibarra, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2023
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targetsKristina W Thiel, Andreea M Newtson, Eric J Devor, et al.
Gynecologic Oncology|May 24, 2017
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group studyHenry D Reyes, Jeffrey Miecznikowski, Jesus Gonzalez-Bosquet, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Gynecologic Oncology|February 5, 2021
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology studyKimberly K Leslie, Virginia L Filiaci, Adrianne R Mallen, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 2019
Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated With Human Preeclampsia and Sufficient to Cause Features of the Disorder in MiceKatherine J Perschbacher, Guorui Deng, Jeremy A Sandgren, et al.
Frontiers in Plant Science|March 5, 2016
RNA Interference for Functional Genomics and Improvement of Cotton (Gossypium sp.)Ibrokhim Y Abdurakhmonov, Mirzakamol S Ayubov, Khurshida A Ubaydullaeva, et al.
Pageof 7